Wax foamable vehicle and pharmaceutical compositions thereof

US9662298B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9662298-B2
Application numberUS-201414161134-A
CountryUS
Kind codeB2
Filing dateJan 22, 2014
Priority dateAug 7, 2007
Publication dateMay 30, 2017
Grant dateMay 30, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. In some embodiments, the wax includes a solid wax and a liquid wax. The compositions are substantially free of crystals. The components are selected to provide a composition that is substantially resistant to aging and to phase separation, and/or can substantially solubilize and or stabilize active ingredients. Pharmaceutical and cosmetic compositions with potentially enhanced skin delivery and their uses are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A foamable composition for a pharmaceutical comprising: A. a carrier comprising: a. at least about 20% by weight of a liquid wax comprising one or more free fatty acids, wherein at least one free fatty acid is oleic acid and wherein the oleic acid is at least about 20% by weight of the carrier; b. a surface-active agent; c. a polymeric agent; and d. a solid wax comprising a solid paraffin wax; wherein the ratio of liquid wax to solid wax is about 3:1 to about 10:1, and B. a liquefied hydrocarbon gas propellant at a concentration of about 3% to about 35% by weight of the foamable composition; wherein the composition has a water content less than about 5% by weight; wherein the composition is not an emulsion; and wherein, upon release from a pressurized container, a breakable foam is produced. 2. The foamable composition of claim 1 , wherein the solid wax further comprises a solid wax selected from the group consisting of a fatty acid, a fatty alcohol, a microcrystalline wax, a petroleum wax, a polyethylene wax, a beeswax, a candelilla wax, a castor wax, a Chinese wax, a Fischer-Tropsch wax, a rice bran wax, a tallow, a wool wax, and a mixture of any two or more thereof. 3. The foamable composition of claim 2 , wherein the solid wax further comprises a solid wax selected from the group consisting of stearic acid, cetyl alcohol, behenyl alcohol, stearyl alcohol, and a mixture of any two or more thereof. 4. The foamable composition of claim 1 , wherein the liquid wax enables the solid wax to solubilize. 5. The foamable composition of claim 1 , wherein solid wax crystals are not visible and the composition is flowable through an aerosol valve. 6. The foamable composition of claim 1 , wherein the polymeric agent is present in the composition at a concentration of about 0.01% to about 5% by weight of the carrier and is selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent, and a phase change agent. 7. The foamable composition of claim 1 , wherein the surface-active agent is selected from the group consisting of a polysorbate, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene (20) sorbitan monooleate, a polyoxyethylene fatty acid ester, polyoxyethylene (8) stearate, polyoxyethylene (20) stearate, polyoxyethylene (40) stearate, polyoxyethylene (100) stearate, a polyoxyethylene alkyl ether, a polyoxyethylene cetyl ether, polyoxyethylene (23) cetyl ether, polyoxyethylene (2) cetyl ether, polyoxyethylene (10) cetyl ether, a sucrose ester, a partial ester of sorbitol, sorbitan monolaurate, a monoglyceride, a diglyceride, isoceteth-20, steareth 2, glyceryl stearate, steareth-21, sorbitan stearate, laureth 4, sorbitan monooleate, ceteareth 20, steareth 20, ceteth 20, macrogol cetostearyl ether, PEG-30 dipolyhydroxystearate, sucrose distearate, cetomacrogol ether, cetearyl glucoside, polysorbate 20; methyl glucose sesquistearate, a sucrose stearic acid ester, a phospholipid, and a mixture of any two or more thereof. 8. The foamable composition of claim 7 , wherein the surface-active agent is selected from the group consisting of sorbitan stearate, glyceryl monostearate, and a mixture thereof. 9. The foamable composition of claim 1 , wherein the surface active agent also functions as a solvent. 10. The foamable composition of claim 1 , wherein the polymeric agent is selected from the group consisting of a cross-linked polyacrylate polymer, acrylates/C10-30 alkyl acrylate crosspolymers, a locust bean gum, sodium alginate, sodium caseinate, an egg albumin, a gelatin agar, a carrageenin gum, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a cationic guar, a hydroxypropyl guar gum, a starch, an amine-bearing polymer, a chitosan, an alginic acid, a hyaluronic acid, a chemically modified starch, a carboxyvinyl polymer, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, a methylcellulose, a hydroxypropyl cellulose, a hydroxypropyl methylcellulose, a hydroxyethyl cellulose, a methylhydroxyethylcellulose, a carboxymethylcellulose, a hydroxyethylcarboxymethylcellulose, a cationic cellulose, an aluminum starch octenylsuccinate, a sodium starch octenylsuccinate, and a mixture of any two or more thereof. 11. The foamable composition of claim 1 , wherein the composition further comprises a solvent selected from the group consisting of an organic carrier, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and a mixture thereof. 12. The foamable composition of claim 11 , wherein the solvent comprises dimethyl sulfoxide. 13. The foamable composition of claim 11 , wherein the solvent comprises a polyethylene glycol. 14. The foamable composition of claim 1 , wherein the surface active agent is between about 0.2% to about 8% by weight. 15. The foamable composition of claim 1 , further comprising an additional component selected from the group consisting of a modulating agent, a polar solvent, an anti perspirant, an anti-static agent, a buffering agent, a bulking agent, a chelating agent, a colorant, a conditioner, a deodorant, a diluent, a dye, an emollient, fragrance, a humectant, an occlusive agent, a penetration enhancer, a perfuming agent, a permeation enhancer, a pH-adjusting agent, a preservative, a skin penetration enhancer, a sunscreen, a sun blocking agent, a sunless tanning agent, a vitamin, and a mixture of any two or more thereof. 16. The foamable composition of claim 1 , further comprising an active agent. 17. The foamable composition of claim 16 , wherein at least 95% of the active ingredient has been solubilized. 18. The foamable composition of claim 16 , wherein the active agent is selected from the group consisting of an active herbal extract, an acaricide, an age spot and keratose removing agent, an allergen, an analgesic, a local anesthetic, an antiacne agent, an antiallergic agent, an antiaging agent, an antibacterial, an antibiotic, an antiburn agent, an anticancer agent, an antidandruff agent, an antidepressant, an antidermatitis agent, an antiedemic, an antihistamine, an antihelminth, an antihyperkeratolyte agent, an antiinflammatory agent, an antiirritant, an antilipemic, an antimicrobial, an antimycotic, an antiproliferative agent, an antioxidant, an anti-wrinkle agent, an antipruritic, an antipsoriatic agent, an antirosacea agent, an antiseborrheic agent, an antiseptic agent, an antiswelling agent, an antiviral agent, an antiyeast agent, an astringent, a topical cardiovascular agent, a chemotherapeutic agent, a corticosteroid, a dicarboxylic acid, a disinfectant, a fungicide, a hair growth regulator, a hormone, a hydroxy acid, an immunosuppressant, an immunoregulating agent, an immunomodulatory, an insecticide, an insect repellent, a keratolytic agent, a lactam, a metal oxide, a mitocide, a neuropeptide, a steroid, a non-steroidal anti-inflammatory agent, an oxidizing agent, a pediculicide, a photodynamic therapy agent, a retinoid, a sanative, a scabicide, a vasoconstrictor, a vasodilator, a vitamin, a vitamin D derivative, a wound healing agent, a wart remover; an agent having activity against superficial basal cell carcinomas, actinic keratoses, Bowen's disease, or other squamous cell carcinomas and molluscum contagiosum; an agent having activity against herpes simplex virus infections, other viral infections, or eczema; a vaccine adjuvant, and a mixture of any two or more thereof.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Nose · CPC title

  • Antidandruff preparations · CPC title

  • Rectum, anus · CPC title

  • Hydrocarbons · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9662298B2 cover?
Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. In some embodiments, the wax includes a solid wax and a liquid wax. The compositions are substantially free of crystals. The components are selected to provide a composition that is substant…
Who is the assignee on this patent?
Foamix Pharmaceuticals Ltd
What technology area does this patent fall under?
Primary CPC classification A61K9/122. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).